MD Anderson Research Highlights for October 30, 2024

Featuring insights into tissue regeneration, biomarkers for COVID-19 severity in cancer patients, cancer vaccines and new alternatives to hypomethylating agents

2024-10-30

(Press-News.org) HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

Epigenetic targets and genomic stem cell pathways drive adult hair regeneration
Retrotransposons are interspersed repeating sequences that make up over 40% of the human genome. Proper tissue regeneration requires they be tightly regulated, but little is known about how this process is coordinated. To provide insights, researchers led by Yejing Ge, Ph.D., studied laboratory models of hair follicle stem cells in the skin. When injured, these stem cells change to help restore the skin barrier but eventually become exhausted. The researchers found an epigenetic regulator, SETDB1, driving retrotransposon suppression to protect regeneration. Removing SETDB1 led to the induction of a viral type of retrotransposon along with viral-like particles, resulting in hair loss and stem cell exhaustion. Antiviral drugs reversed this condition and led to hair cell regeneration. The researchers identified at least two involved pathways – antiviral-dependent and independent host responses toward reactivated retrotransposons – which potentially can be leveraged to deter tumor development and innovate cancer treatments. Learn more in Cell.

MicroRNAs serve as potential blood biomarkers for COVID-19 severity in cancer patients
Immunocompromised cancer patients who are infected by SARS-CoV-2 are at risk of developing severe COVID-19 with potentially fatal complications. Biomarkers capable of predicting those most at risk could help physicians better treat these patients. Researchers led by Simone Anfossi, Ph.D., and George Calin, M.D., Ph.D., identified several microRNAs – small non-coding RNA molecules – located close to genomic regions associated with the severity and susceptibility of COVID-19. The researchers analyzed plasma samples from 128 cancer patients infected by SARS-CoV-2. Levels of specific circulating microRNAs were associated with an increased risk of COVID-19-related death, making them an attractive prognostic biomarker. Further investigation is needed to understand this association, but similar methods could also identify at-risk patients for other common viral infections, like influenza, seasonal coronaviruses and cold viruses, which can negatively impact cancer patient prognoses. Learn more in Molecular Cancer.

Novel protein complex drives lung regeneration and suppresses lung fibrosis
Many chronic lung diseases lead to fibrosis, a condition in which lung tissue becomes irreversibly scarred and stiff, partly due to a failure in activating cell regeneration. Researchers led by Bongjun Kim, Ph.D., and Jae-Il Park, Ph.D., used a comprehensive approach to examine the mechanisms involved in lung cell repair. They identified a protein complex, PCLAF-DREAM, that plays a crucial role in helping lung cells regenerate after injury. The complex transforms specific precursor cells in lung alveola into a different type of cell that facilitates lung repair and oxygen exchange. In lab models, reducing PCLAF led to impaired lung regeneration and the development of fibrosis. The study also identified a viable drug candidate, phenelzine, that closely mimics the effects of this complex, suppressing lung fibrosis and promoting regeneration. Understanding the processes and pathways involved in alveolar cell regeneration can inform novel treatment strategies to help prevent lung fibrosis in patients with various lung diseases. Learn more in Nature Communications.

Vaccine-based combination therapy improves antitumor immune responses in melanoma
Tumor-specific neoantigens (neoAgs) are unique to cancer cells, making them viable targets for therapeutic cancer vaccines. However, little is known about the mechanisms underlying these neoAg vaccines and how they compare to immune checkpoint therapy (ICT). Researchers led by Sunita Keshari, Ph.D., and Matthew Gubin, Ph.D., characterized changes within immune populations following treatment with neoAg vaccines and ICT in models of melanoma, leading them to identify cell subsets and potential biomarkers that provide insights for improving treatment strategies. The study highlighted differences in the way neoAg vaccines and ICT affect immune cells, discovering that combining neoAg vaccines with ICT elicited a greater immune response in these models. Additionally, they noted that a specific type of suppressive macrophage expressing TREM2 expanded after vaccine treatment, but these cells were suppressed by ICT. Adding TREM2 blockade to the neoAg vaccine blunted this suppressive macrophage population, further enhancing neoAg vaccine efficacy. Learn more in Cell Reports.

Study evaluates alternatives to hypomethylating agents
Hypomethylating agents, like azacitidine and decitabine, block epigenetic DNA methylation. These drugs are standard treatments for hematological disorders but come with dose-limiting toxic side effects, highlighting a need for other treatment options. Quinoline-based compounds also can induce DNA demethylation, offering a promising alternative. To provide further insights, Xiaodong Cheng, Ph.D., led a group of scientists in characterizing the epigenetic effects of 15 quinoline-based compounds on human and bacterial DNA methyltransferases. Six of the compounds inhibited DNA methyltransferases, while two also significantly changed the shape of the DNA to inhibit various enzymes, leading to apoptosis, or programmed cell death. Additionally, one compound also elicited a DNA damage response in cancer cells via activation of the wild-type p53 tumor suppressor. The study highlights the potential of quinoline-based compounds to target cancers harboring wild-type p53. Learn more in Cell Chemical Biology.

Awards and honors

Khaled Elsayes, M.D., professor of Abdominal Imaging, and Carin Hagberg, M.D., professor of Anesthesiology and Perioperative Medicine, were awarded the 2024 Regents Outstanding Teaching Awards by The University of Texas System Board of Regents Phyu Aung, M.D., Ph.D., professor of Pathology, was awarded the Lifetime Achievement Award by the College of American Pathologists (CAP) In case you missed it
Read below to catch up on recent MD Anderson press releases.

Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer MD Anderson expands arts experience program to enhance healing and well-being for patients Funda Meric-Bernstam, M.D., elected to National Academy of Medicine Read this press release in the MD Anderson Newsroom.

- 30 -

END

ELSE PRESS RELEASES FROM THIS DATE:

Three Baycrest leaders named 2024 Canada’s Most Powerful Women: WXN’s Top 100 Award winners

2024-10-30

Toronto, ON, October 30, 2024 – Three Baycrest leaders are among those named winners of Women Executive Network’s (WXN) prestigious 2024 Canada’s Most Powerful Women: Top 100 Awards, celebrating exceptional leadership and groundbreaking achievements that have meaningfully transformed their industries, companies, communities and country. Dr. Allison Sekuler, President and Chief Scientist, Baycrest Academy for Research and Education and President and Chief Scientist, Centre for Aging + Brain Health Innovation, powered by Baycrest (CABHI) Dr. ...

Scientists uncover new mechanism in plant cold sensing

2024-10-30

Cold damage is a major challenge in rice production, and identifying key gene modules in signaling pathways is a crucial means of addressing this issue. A Chinese research team has recently discovered a part of the plant’s cell membrane that helps plants sense when it's cold. This cell membrane component, known as the COLD6-OSM1 module, triggers the production of a special molecule, 2',3'-cAMP, which helps plants sense and respond to low temperatures. This secondary messenger is a key upstream component that mediates the signaling pathway by directly responding to signals ...

Study shows natural regrowth of tropical forests has immense potential to address environmental concerns

2024-10-30

A new study in Nature finds that up to 215 million hectares of land (an area larger than Mexico) in humid tropical regions around the world has the potential to naturally regrow. That much forest could store 23.4 gigatons of carbon over 30 years and also have a significant impact on concerns like biodiversity loss and water quality. The study showed that more than half of the area with strong potential for regrowth was in five countries: Brazil, Mexico, Indonesia, China, and Colombia. “Tree planting in degraded landscapes can be costly. By leveraging natural regeneration techniques, nations can meet their ...

After a heart attack, the heart signals to the brain to increase sleep to promote healing

2024-10-30

A heart attack can trigger a desire to get more sleep, allowing the heart to heal and reduce inflammation—and this happens because the heart sends special signals to the brain, according to a new Mount Sinai study. This research is the first to demonstrate how the heart and brain communicate with each other through the immune system to promote sleep and recovery after a major cardiovascular event. The novel findings, published October 30 in Nature, emphasize the importance of increased sleep after a heart attack, and suggest that sufficient sleep should be a focus of post-heart-attack clinical management ...

Complexity of tumors revealed in 3D

2024-10-30

A new analysis led by researchers at Washington University School of Medicine in St. Louis has revealed detailed 3D maps of the internal structures of multiple tumor types. These cancer atlases reveal how different tumor cells — and the cells of a tumor’s surrounding environment — are organized, in 3D, and how that organization changes when a tumor spreads to other organs. The detailed findings offer scientists valuable blueprints of tumors that could lead to new approaches to therapy and spark a new era in the field of cancer biology, according to the researchers. The study is part of a group of 12 papers published Oct. 30 in the Nature suite of journals by members ...

Into the great wide open: How steppe pastoralist groups formed and transformed over time

2024-10-30

The wider Caucasus region, between the Black and the Caspian Seas, connects Europe, the Near East and Asia. It displays a huge geographic, ecological, economic, cultural, and linguistic range today, from the steppe zone in the north, the Caucasus mountains in the center, to the highlands of today’s Armenia, Georgia, Azerbaijan and Iran in the south. This diversity was no different in the past, where the archaeological record attests to many different influences from many surrounding regions. “It is precisely this interface of different eco-geographic features ...

Determining precise timing of cellular growth to understand the origins of cancer

2024-10-30

Cancers are diseases of abnormal cellular growth, and although many are treatable or even curable, their origins are not necessarily clear. Understanding the precise timing of cellular events—as cells transition from normal to cancerous conditions—is key to uncovering new treatments or diagnostic opportunities. Scientists from Vanderbilt University, led by Mirazul Islam, a graduate student mentored by Professor of Cell and Developmental Biology Ken Lau and Professor of Medicine Robert Coffey, have laid the groundwork for understanding and predicting the natural transition between precancers and cancer. They showed that colorectal cancer is likely to ...

Healthy brains suppress inappropriate immune responses

2024-10-30

The brain constantly engages in dialogue with the body’s immune system. Such communication appears aimed at ensuring a delicate balance between defending against injury and infection and guarding healthy tissue. Now, scientists at Washington University School of Medicine in St. Louis have revealed how the two strike a healthy balance. The study, in mice, found that fragments of immune-stimulating proteins – dubbed guardian peptides – are produced by the brain and spinal cord of the central nervous system to maintain ...

Large meltwater accumulation revealed inside Greenland Ice Sheet

2024-10-30

A new study published in Nature unveils a surprising discovery: a substantial amount of meltwater is temporarily stored within the Greenland Ice Sheet during summer months. For the first time, an international group of researchers was able to quantify meltwater with positioning data. The finding challenges current models of how ice sheets contribute to global sea level rise. The Greenland Ice Sheet is currently the largest single contributor to global sea-level rise, with the potential to raise the mean sea level by up to seven meters if it fully melts. While ...

Ancient DNA brings to life history of the iconic aurochs, whose tale is intertwined with climate change and human culture

2024-10-30

Geneticists from Trinity College Dublin, together with an international team of researchers, have deciphered the prehistory of aurochs – the animals that were the focus of some of the most iconic early human art – by analysing 38 genomes harvested from bones dating across 50 millennia and stretching from Siberia to Britain. The aurochs roamed in Europe, Asia and Africa for hundreds of thousands of years. Adorned as paintings on many a cave wall, their domestication to create cattle gave us a harnessed source of muscle, meat and milk. Such ...